Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209039495> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W3209039495 endingPage "107" @default.
- W3209039495 startingPage "101" @default.
- W3209039495 abstract "The use of targeted drug therapies has substantially increased in the treatment of RET-mutated thyroid and other solid cancers over the last decade. Multi-Kinase Inhibitors (MKI) have been approved by FDA, but limited efficacies and side effects make them uneasy to tolerate. Pralsetinib is an oral highly selective RET inhibitor drug that has been generated and clinically validated to have higher potency and less toxicity.The present paper offers a brief summary of RET-related thyroid cancer genetics, an overview of the preclinical development of pralsetinib and reviews its clinical validation in the treatment of thyroid cancer.Pralsetinib is a new generation oral treatment that has been approved by the FDA for patients with RET-mutated thyroid cancer. Pralsetinib showed a safer toxicity profile compared to previously approved MKI, probably due to lower inhibition of other tyrosine kinases, especially VEGFR. The approval study ARROW trial showed that patients with RET-mutant medullary thyroid cancer had a better overall response rate to pralsetinib compared to standard-of-care treatments. Additional clinical trials or data enrichment of existing databases are desirable in order to verify and further describe the clinical benefit of pralsetinib in such patients to fully understand its pharmacological profile." @default.
- W3209039495 created "2021-11-08" @default.
- W3209039495 creator A5005594699 @default.
- W3209039495 creator A5010989159 @default.
- W3209039495 creator A5066308893 @default.
- W3209039495 creator A5074839378 @default.
- W3209039495 creator A5088220553 @default.
- W3209039495 creator A5088329463 @default.
- W3209039495 date "2021-10-27" @default.
- W3209039495 modified "2023-10-02" @default.
- W3209039495 title "Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer" @default.
- W3209039495 cites W1848939527 @default.
- W3209039495 cites W1968517866 @default.
- W3209039495 cites W1969870912 @default.
- W3209039495 cites W2058185583 @default.
- W3209039495 cites W2069347512 @default.
- W3209039495 cites W2071749936 @default.
- W3209039495 cites W2119501407 @default.
- W3209039495 cites W2122956665 @default.
- W3209039495 cites W2163083568 @default.
- W3209039495 cites W2169175507 @default.
- W3209039495 cites W2271763089 @default.
- W3209039495 cites W2509850363 @default.
- W3209039495 cites W2618891896 @default.
- W3209039495 cites W2797098362 @default.
- W3209039495 cites W2972775239 @default.
- W3209039495 cites W2981271513 @default.
- W3209039495 cites W3008903497 @default.
- W3209039495 cites W3012017822 @default.
- W3209039495 cites W3030970049 @default.
- W3209039495 cites W3042472140 @default.
- W3209039495 cites W3098982779 @default.
- W3209039495 cites W3121847312 @default.
- W3209039495 cites W3166643980 @default.
- W3209039495 cites W3172213464 @default.
- W3209039495 cites W4205727675 @default.
- W3209039495 cites W4233591965 @default.
- W3209039495 doi "https://doi.org/10.1080/17460441.2022.1995351" @default.
- W3209039495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34702125" @default.
- W3209039495 hasPublicationYear "2021" @default.
- W3209039495 type Work @default.
- W3209039495 sameAs 3209039495 @default.
- W3209039495 citedByCount "5" @default.
- W3209039495 countsByYear W32090394952022 @default.
- W3209039495 countsByYear W32090394952023 @default.
- W3209039495 crossrefType "journal-article" @default.
- W3209039495 hasAuthorship W3209039495A5005594699 @default.
- W3209039495 hasAuthorship W3209039495A5010989159 @default.
- W3209039495 hasAuthorship W3209039495A5066308893 @default.
- W3209039495 hasAuthorship W3209039495A5074839378 @default.
- W3209039495 hasAuthorship W3209039495A5088220553 @default.
- W3209039495 hasAuthorship W3209039495A5088329463 @default.
- W3209039495 hasConcept C121608353 @default.
- W3209039495 hasConcept C126322002 @default.
- W3209039495 hasConcept C143998085 @default.
- W3209039495 hasConcept C2779761222 @default.
- W3209039495 hasConcept C2780035454 @default.
- W3209039495 hasConcept C2780120053 @default.
- W3209039495 hasConcept C526584372 @default.
- W3209039495 hasConcept C535046627 @default.
- W3209039495 hasConcept C64903051 @default.
- W3209039495 hasConcept C71924100 @default.
- W3209039495 hasConcept C98274493 @default.
- W3209039495 hasConceptScore W3209039495C121608353 @default.
- W3209039495 hasConceptScore W3209039495C126322002 @default.
- W3209039495 hasConceptScore W3209039495C143998085 @default.
- W3209039495 hasConceptScore W3209039495C2779761222 @default.
- W3209039495 hasConceptScore W3209039495C2780035454 @default.
- W3209039495 hasConceptScore W3209039495C2780120053 @default.
- W3209039495 hasConceptScore W3209039495C526584372 @default.
- W3209039495 hasConceptScore W3209039495C535046627 @default.
- W3209039495 hasConceptScore W3209039495C64903051 @default.
- W3209039495 hasConceptScore W3209039495C71924100 @default.
- W3209039495 hasConceptScore W3209039495C98274493 @default.
- W3209039495 hasIssue "2" @default.
- W3209039495 hasLocation W32090394951 @default.
- W3209039495 hasLocation W32090394952 @default.
- W3209039495 hasOpenAccess W3209039495 @default.
- W3209039495 hasPrimaryLocation W32090394951 @default.
- W3209039495 hasRelatedWork W1603416295 @default.
- W3209039495 hasRelatedWork W2118630726 @default.
- W3209039495 hasRelatedWork W2329258414 @default.
- W3209039495 hasRelatedWork W2372770165 @default.
- W3209039495 hasRelatedWork W3024269876 @default.
- W3209039495 hasRelatedWork W3049299998 @default.
- W3209039495 hasRelatedWork W3131976426 @default.
- W3209039495 hasRelatedWork W3202735287 @default.
- W3209039495 hasRelatedWork W3209039495 @default.
- W3209039495 hasRelatedWork W2520205720 @default.
- W3209039495 hasVolume "17" @default.
- W3209039495 isParatext "false" @default.
- W3209039495 isRetracted "false" @default.
- W3209039495 magId "3209039495" @default.
- W3209039495 workType "article" @default.